BRAIN Biotech AG, formerly known as BRAIN Biotechnology Research and Information Network AG is a Germany-based industrial biotechnology company develops and brings to market biological ingredients for Nutrition & Health, SkinCare and Industrial BioSolutions. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 27.2K |
| Three Month Average Volume | 281.6K |
| High Low | |
| Fifty-Two Week High | 4.7 EUR |
| Fifty-Two Week Low | 1.65 EUR |
| Fifty-Two Week High Date | 07 Sep 2023 |
| Fifty-Two Week Low Date | 30 Aug 2024 |
| Price and Volume | |
| Current Price | 1.7 EUR |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -19.32% |
| Thirteen Week Relative Price Change | -40.74% |
| Twenty-Six Week Relative Price Change | -58.35% |
| Fifty-Two Week Relative Price Change | -68.39% |
| Year-to-Date Relative Price Change | -58.90% |
| Price Change | |
| One Day Price Change | 0.29% |
| Thirteen Week Price Change | -39.72% |
| Twenty-Six Week Price Change | -55.50% |
| Five Day Price Change | -3.41% |
| Fifty-Two Week Price Change | -62.22% |
| Year-to-Date Price Change | -53.55% |
| Month-to-Date Price Change | 0.29% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 0.99645 EUR |
| Book Value Per Share (Most Recent Quarter) | 0.74855 EUR |
| Tangible Book Value Per Share (Last Fiscal Year) | 0.30003 EUR |
| Tangible Book Value Per Share (Most Recent Quarter) | 0.74855 EUR |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.0438 EUR |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 2.57352 EUR |
| Revenue Per Share (Trailing Twelve Months) | 2.57517 EUR |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 0 EUR |
| Dividend Per Share (Trailing Twelve Months) | 0 EUR |
| Dividend Per Share (5 Year) | 0 EUR |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.37895 EUR |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.40156 EUR |
| Normalized (Last Fiscal Year) | -0.37064 EUR |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.37895 EUR |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.40156 EUR |
| Including Extraordinary Items (Last Fiscal Year) | -0.37895 EUR |
| Including Extraordinary Items (Trailing Twelve Months) | -0.40156 EUR |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.24749 EUR |
| Cash Per Share (Most Recent Quarter) | -99999.99 EUR |
| Cash Flow Per Share (Last Fiscal Year) | -0.15837 EUR |
| Cash Flow Per Share (Trailing Twelve Months) | -0.18396 EUR |
| Free Cash Flow Per Share (Trailing Twelve Months) | -0.11022 EUR |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -17 |
| Cash Flow Revenue (Trailing Twelve Months) | -4 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -14.92% |
| Pretax Margin (Last Fiscal Year) | -13.32% |
| Pretax Margin (5 Year) | -17.34% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 55.16% |
| Gross Margin (Trailing Twelve Months) | 56.66% |
| Gross Margin (5 Year) | 56.16% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -9.75% |
| Operating Margin (Trailing Twelve Months) | -10.53% |
| Operating Margin (5 Year) | -14.72% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -14.43% |
| Net Profit Margin (Trailing Twelve Months) | -15.71% |
| Net Profit Margin (5 Year) | -17.47% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -5.22% |
| Tangible Book Value (5 Year) | 8.04% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -0.03% |
| Revenue Growth (3 Year) | 14.12% |
| Revenue Change (Trailing Twelve Months) | 2.86% |
| Revenue Per Share Growth | 9.85% |
| Revenue Growth (5 Year) | 12.91% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 14.47% |
| Total Debt (5 Year) | -5.01% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -39.43% |
| EPS Change (Trailing Twelve Months) | -31.73% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 6 |
| Price to Tangible Book (Most Recent Quarter) | 2 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 0 |
| Net Debt (Last Fiscal Year) | 16.1M |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 1 |
| Price to Sales (Trailing Twelve Months) | 1 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | 0.00% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 2 |
| Price to Book (Most Recent Quarter) | 2 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 82 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | -100,000 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 3 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -6,856,000 |
| Free Cash Flow (Trailing Twelve Months) | -2,408,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -1 |
| Net Interest Coverage (Trailing Twelve Months) | -2 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 99 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -10.90% |
| Return on Assets (Trailing Twelve Months) | -12.31% |
| Return on Assets (5 Year) | -10.71% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -32.21% |
| Return on Equity (Trailing Twelve Months) | -44.22% |
| Return on Equity (5 Year) | -31.95% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -15.57% |
| Return on Investment (Trailing Twelve Months) | -15.45% |
| Return on Investment (5 Year) | -14.46% |